General Information
Version
8.6
Revision date
2024-01-25
Product name
Ni(COD)(DQ)
CAS No.
40759-64-6
REACH No
A
Emergency telephone
800-424-9300, +1-703- 527-3887
Icons in SDS
Company Information
company name
Sigma-Aldrich Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H351, H372
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Skin sensitization, (Category 1) H317: May cause an allergic skin reaction. Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Specific target organ toxicity - H372: Causes damage to organs through repeated exposure, (Category 1), prolonged or repeated exposure. Lungs
Signal word
Danger Danger
Hazard statements
H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. H372 Causes damage to organs (Lungs) through prolonged or repeated exposure. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. H372 Causes damage to organs through prolonged or repeated exposure.
Precautionary statements
P201 Obtain special instructions before use. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
